Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
作者信息
Regmi Subodh K, Konety Badrinath R
机构信息
Department of Urology, University of Minnesota Medical School, Minneapolis, MN, USA.
出版信息
Transl Androl Urol. 2019 Jul;8(Suppl 3):S314-S317. doi: 10.21037/tau.2019.06.06.
Abstract
摘要
相似文献
1
Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?研究合并症对根治性膀胱切除术后生存率的影响：我们是否又回到了原点？
Transl Androl Urol. 2019 Jul;8(Suppl 3):S314-S317. doi: 10.21037/tau.2019.06.06.
2
Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.根治性膀胱切除术治疗后合并症与总生存期和膀胱癌特异性生存期的相关性：来自艾伯塔省泌尿外科研究所根治性膀胱切除术数据库的结果。
J Urol. 2009 Jul;182(1):85-92; discussion 93. doi: 10.1016/j.juro.2008.11.111. Epub 2009 May 17.
3
A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.约克郡根治性膀胱切除术和根治性放疗治疗浸润性膀胱癌后的发病率、死亡率及长期生存率研究。
Eur Urol. 2003 Mar;43(3):246-57. doi: 10.1016/s0302-2838(02)00581-x.
4
Comorbidity relationship to outcome of radical cystectomy in Chinese: a single institution study with the ACE-27 comorbidity index.
Asian Pac J Cancer Prev. 2012;13(3):827-31. doi: 10.7314/apjcp.2012.13.3.827.
5
Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.比较几种合并症指数在预测膀胱癌根治性切除术围手术期和 5 年全因死亡率方面的性能。
J Urol. 2013 Jul;190(1):55-60. doi: 10.1016/j.juro.2013.01.010. Epub 2013 Jan 9.
6
[Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer].[合并症对膀胱癌根治性膀胱切除术患者死亡率和发病率的影响]
Aktuelle Urol. 2015 May;46(3):236-41. doi: 10.1055/s-0035-1550036. Epub 2015 Jun 12.
7
Radical cystectomy and the implications of comorbidity.根治性膀胱切除术及合并症的影响。
Expert Rev Anticancer Ther. 2014 Mar;14(3):289-95. doi: 10.1586/14737140.2014.868775. Epub 2014 Jan 8.
8
[Impact of comorbidity on perioperative mortality after radical cystectomy].[合并症对根治性膀胱切除术后围手术期死亡率的影响]
Aktuelle Urol. 2008 May;39(3):225-8. doi: 10.1055/s-2008-1038161.
9
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.年龄校正后的查尔森合并症评分与接受膀胱癌根治性膀胱切除术患者的治疗决策和临床结局相关。
Cancer. 2008 Jun;112(11):2384-92. doi: 10.1002/cncr.23462.
10
Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database.根治性膀胱切除术后年龄、合并症与临床结局之间的关联：艾伯塔大学泌尿外科研究所根治性膀胱切除术数据库的结果
J Urol. 2008 Jul;180(1):128-34; discussion 134. doi: 10.1016/j.juro.2008.03.057. Epub 2008 May 15.
引用本文的文献
1
Radical cystectomy for bladder cancer in Sub-Saharan Africa: techniques, challenges, and survival outcomes: a comprehensive review.撒哈拉以南非洲地区膀胱癌根治性膀胱切除术：技术、挑战及生存结果：一项综合综述
BMC Surg. 2025 Apr 8;25(1):143. doi: 10.1186/s12893-025-02887-9.
2
Highlighting the road towards new disease-specific comorbidity indices.突出通往新的疾病特异性合并症指数的道路。
Transl Androl Urol. 2020 Jun;9(3):1475-1478. doi: 10.21037/tau-20-832.
本文引用的文献
1
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.宿主分期：为根治性膀胱切除术患者进行个体化风险评估。
Eur Urol Oncol. 2018 Sep;1(4):292-304. doi: 10.1016/j.euo.2018.05.010. Epub 2018 Jun 19.
2
Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.膀胱癌患者根治性膀胱切除术前肾积水与预后的关联：一项系统评价和Meta分析
Front Oncol. 2019 Mar 19;9:158. doi: 10.3389/fonc.2019.00158. eCollection 2019.
3
Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.开发一种新的合并症评估工具，用于特定预测接受根治性膀胱切除术的当代患者的围手术期死亡率。
Ann Surg Oncol. 2019 Jun;26(6):1942-1949. doi: 10.1245/s10434-019-07313-y. Epub 2019 Mar 27.
4
Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments.衰弱作为根治性膀胱切除术后并发症的预测指标：一项关于各种术前评估的前瞻性研究。
Urol Oncol. 2019 Jan;37(1):40-47. doi: 10.1016/j.urolonc.2018.10.002. Epub 2018 Nov 15.
5
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients.膀胱癌患者合并症与竞争风险评估的系统评价
Eur Urol Oncol. 2018 Jun;1(2):91-100. doi: 10.1016/j.euo.2018.03.005. Epub 2018 Jun 6.
6
Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.常用指标预测根治性膀胱切除术不良结局的判别能力：人口统计学数据、美国麻醉医师协会、改良 Charlson 合并症指数和改良衰弱指数的比较。
Clin Genitourin Cancer. 2018 Aug;16(4):e843-e850. doi: 10.1016/j.clgc.2018.02.009. Epub 2018 Feb 26.
7
Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.膀胱癌根治性膀胱切除术后 90 天内的并发症：日本多中心前瞻性研究结果。
Int J Clin Oncol. 2018 Aug;23(4):734-741. doi: 10.1007/s10147-018-1245-z. Epub 2018 Feb 13.
8
Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-making.接受根治性膀胱切除术的膀胱癌患者的癌症及全因死亡率：用于治疗决策的列线图的开发与验证
Urology. 2017 Dec;110:76-83. doi: 10.1016/j.urology.2017.08.024. Epub 2017 Aug 25.
9
Prospects and progress of immunotherapy for bladder cancer.膀胱癌免疫治疗的前景与进展
Expert Opin Biol Ther. 2017 Nov;17(11):1417-1431. doi: 10.1080/14712598.2017.1366445. Epub 2017 Aug 23.
10
Burden of Multiple Chronic Conditions among Patients with Urological Cancer.泌尿系统癌症患者的多重慢性疾病负担。
J Urol. 2018 Feb;199(2):543-550. doi: 10.1016/j.juro.2017.08.005. Epub 2017 Aug 5.
Zotero 插件